The Middle East and Africa Medical Cannabis Market size was valued at USD 1.34 billion in 2025 and is projected to grow from USD 1.48 billion in 2026 to reach USD 3.26 billion by 2034, growing at a CAGR of 10.37% during the forecast period 2026–2034.
Medical cannabis, also known as medical marijuana, is a herbal medication derived from Cannabis plants used to treat specific symptoms or diseases, such as cancer, chronic pain, and psychiatric disorders. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main cannabinoids extracted from this plant that provide medicinal benefits.
It is anticipated that the advancement of medicinal cannabis will fuel the development of this industry over the coming years through clinical trials and judgments made by regulatory agencies in developed countries. In addition, it is anticipated that over the forecast period, the status of medicinal cannabis will improve because of clinical trials and decisions taken by regulatory agencies in developed countries. But the market is constrained by a dearth of knowledge about the advantages of medical marijuana and strict regulatory requirements.
Download a Free Sample To learn more about this report,
In the Middle East and Africa, the population is affected by several chronic diseases, including glaucoma, multiple sclerosis, epilepsy, spasticity brought on by multiple sclerosis or spinal cord injury, fibromyalgia, and chemotherapy-induced nausea and vomiting. Because there is strong evidence that cannabis is an effective treatment for many ailments, the demand for cannabis-based medications is rising along with the prevalence of these conditions.
The acceptance of medical marijuana is rising gradually throughout the Middle East and Africa region. This change is ascribed to several things, including rising knowledge of cannabis' therapeutic potential, successful patient tales, and changing societal attitudes toward alternative medicine. The acceptance and demand for medical cannabis are anticipated to increase as more patients and healthcare professionals realize its effectiveness in treating chronic pain, epilepsy, and cancer-related symptoms.
Chronic diseases like cancer, HIV/AIDS, multiple sclerosis, and chronic pain problems are becoming more common in the Middle East and Africa. Medical marijuana has shown promise in easing the symptoms of various diseases, offering relief, and enhancing patients' quality of life. The demand for medical cannabis as an alternative or supplementary therapy is anticipated to soar in the Middle East and Africa as chronic disease burdens rise.
Cannabis has been shown to have positive health impacts, but it also has negative ones. Heavy or prolonged cannabis usage has been linked to addiction, altered brain development, decreased life satisfaction, cognitive impairment, and poor educational outcomes, according to a 2017 study published in the Pharmacy and Therapeutics journal. According to a study, dizziness was the non-serious side effect that participants exposed to cannabinoids reported occurring the most frequently (15.5% of the time). Chronic bronchitis and psychosis-related health issues are also more likely to develop in cannabis users over the long term. It is clear from the available data that cannabis' negative side effects can have a significant negative influence on market expansion.
There is a growing awareness about the benefits of medical cannabis. People are becoming more aware of the potential of medical cannabis to treat a variety of conditions. This is leading to an increase in the demand for medical cannabis products.
The Middle East and Africa Medical Cannabis Market is segmented into Flowers, Concentrates, Topicals & Transdermal Formulations, Oils & Tinctures, and Other Product Types. Flowers include dried cannabis products used for medical purposes where permitted under applicable regulations, while concentrates contain higher concentrations of cannabinoids for selected therapeutic applications. Topicals and transdermal formulations are designed for localized or systemic delivery through the skin, whereas oils and tinctures provide controlled administration and dosing flexibility. Oils & Tinctures represent an important product category because of their convenient administration and suitability for controlled cannabinoid delivery, while increasing development of regulated medical cannabis formulations is supporting product diversification across the region.
Growing interest in cannabis-based therapies, increasing research activities, gradual development of regulatory frameworks, and improvements in extraction and formulation technologies are supporting demand across product categories. Flowers continue to represent a relevant product type in markets where medical use is legally permitted, while concentrates are benefiting from advancements in cannabinoid extraction and standardized formulations. Topical and transdermal products are creating opportunities for localized applications, while oils and tinctures are gaining attention because of their flexible dosing and ease of administration. Continued regulatory development, pharmaceutical research, and increasing awareness of potential therapeutic applications are expected to support further growth across product types.
Request Customizationto receive a tailored report.
The Middle East and Africa Medical Cannabis Market is segmented into Oncology, Chronic Pain Management, Mental Health Management, Neurological Disease Management, and Other Applications. Oncology applications include supportive management of selected symptoms associated with cancer and its treatment, while chronic pain management represents an important therapeutic area because of the burden of persistent pain conditions. Mental Health Management includes selected applications related to conditions such as anxiety and other disorders, while Neurological Disease Management covers conditions such as epilepsy, multiple sclerosis, and other neurological disorders. Other Applications include additional therapeutic areas where medical cannabis products may be considered under applicable clinical and regulatory frameworks.
Chronic Pain Management represents a significant application area due to the prevalence of persistent pain and growing interest in alternative therapeutic approaches. Oncology applications are also gaining attention for selected treatment-related symptoms, while Neurological Disease Management is supported by increasing research into conditions such as epilepsy and multiple sclerosis. Mental Health Management is developing alongside ongoing research into cannabinoid-based therapies. Increasing clinical research, physician awareness, healthcare development, and gradual acceptance of regulated cannabis-based medicines are expected to support application growth across the Middle East and Africa.
The Middle East and Africa Medical Cannabis Market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies. Hospital pharmacies distribute prescribed medical cannabis products within healthcare institutions and are particularly relevant for physician-supervised treatment and specialized patient care. Drug Stores & Retail Pharmacies provide access to eligible patients in markets where medical cannabis distribution through pharmacies is permitted, while Online Pharmacies offer digital ordering and delivery capabilities where legally authorized. Hospital pharmacies represent an important channel because regulated medical cannabis products require appropriate dispensing, prescription management, and patient guidance.
Drug Stores & Retail Pharmacies can benefit from the development of regulated pharmaceutical distribution networks and increasing availability of approved cannabis-based medicines, while Online Pharmacies may gain opportunities as digital healthcare and e-pharmacy services expand. Hospital pharmacies remain important for specialized and clinically supervised treatments, particularly where medical cannabis is integrated into formal healthcare pathways. Regulatory clarity, improvements in healthcare infrastructure, increasing digitalization of pharmaceutical services, and gradual expansion of prescription-based access are expected to support the development of distribution channels across the Middle East and Africa.
Speak to an Analystto discuss market opportunities.
The Middle East and Africa medical cannabis market is expected to grow at a CAGR of 20.4% during the forecast period.
Due to some key issues, like weak rules and lower adoption rates, the Middle East would see the least market growth. Due to rigorous government rules, it is anticipated that the region will only experience limited growth. Due to the negative consequences of cannabis and the illicit use of marijuana, the industry is also anticipated to grow slowly. Few Arab nations in the Middle East have strong rules governing the use and handling of cannabis-related items. As a result, there is little room for market expansion in these areas over the predicted period. 2020 saw Lebanon become the first Arab nation to legalize cannabis for both medical and industrial purposes.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Precision Cardiology Market Size, Share, Growth, Analysis, 2034
Europe Aesthetic Medicine Market Size, Top Share, Forecast ,2034
Latin America Neurodegenerative Diseases Market Includes Latest Trends, 2034
Asia Pacific Neurodegenerative Diseases Market Size, Share by 2034
LAMEA Lidocaine Market Size, Growth , 2026-2034
North America Neurodegenerative Disease Market Size, 2034
We are featured on:
sales@straitsresearch.com